• Skip to main content
  • Skip to secondary menu
  • Skip to primary sidebar
  • Skip to secondary sidebar
  • Skip to footer

  • Opinion
  • Health IT
    • Behavioral Health
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Patient Engagement
    • Population Health Management
    • Revenue Cycle Management
    • Social Determinants of Health
  • Digital Health
    • AI
    • Blockchain
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • M&A
  • Value-based Care
    • Accountable Care (ACOs)
    • Medicare Advantage
  • Life Sciences
  • Research

Imprivata Completes Zebra Technologies Validation for Mobile Device Access

by Fred Pennic 10/16/2018 Leave a Comment

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print

The Imprivata Report on the Economic Impact of Inefficient Communications in Healthcare

Imprivata,  a healthcare IT security company, today announced that it has successfully completed Zebra Technologies’Validated Program for Imprivata Mobile Device Access, healthcare’s only mobile authentication solution that enables fast, secure access to clinical mobile devices and applications. This designation indicates to customers and partners that Imprivata Mobile Device Access was successfully tested – confirming its performance and functionality with select Zebra® devices.

The Imprivata-Zebra solution allows users to access Zebra’s clinical mobile devices with the simple tap of a proximity badge, then single sign-on into their applications. This gives clinicians the same fast, efficient, and familiar authentication workflow they currently experience on workstations and virtual desktops with Imprivata OneSign®.

Zebra Technologies’ Validated Program is part of the PartnerConnect ISV program and enables eligible channel partners to test the interoperability of their software solutions with select Zebra mobile computers, scanners, printers, RFID readers, payment systems, and mobility management software products, meet user application-specific needs, and reduce both the risk and the deployment time for the user.

Working closely with Zebra engineering teams, Imprivata has tested for interoperability its Mobile Device Access solution with select products, including the innovative Zebra TC51-HC, to remove repetitive manual password entry with a badge tap to gain access.

“Healthcare organizations will derive great value from our solution’s validation from Zebra because it gives them better control over security and the sharing of personal health information,” said Rod Hodgman, Vice President of Business Development at Imprivata. “Imprivata Mobile Device Access delivers real ROI to healthcare organizations because it helps them optimize their investments in mobile hardware without compromising security of PHI or usability and accessibility for clinicians.”

 

In addition, Imprivata has also completed Zebra Technologies’ Validated Program for Imprivata Cortext®, the secure communications platform for healthcare that streamlines care coordination and improves communication efficiency with HIPAA-compliant secure messaging, by allowing physicians, nurses, and patients to connect, communicate, and collaborate securely from any workstation or mobile device.

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print

Tagged With: Imprivata

Tap Native

Get in-depth healthcare technology analysis and commentary delivered straight to your email weekly

Reader Interactions

Primary Sidebar

Subscribe to HIT Consultant

Latest insightful articles delivered straight to your inbox weekly.

Submit a Tip or Pitch

Featured Insights

2025 EMR Software Pricing Guide

2025 EMR Software Pricing Guide

Featured Interview

Paradigm Shift in Diabetes Care with Studio Clinics: Q&A with Reach7 Founder Chun Yong

Most-Read

Medtronic to Separate Diabetes Business into New Standalone Company

Medtronic to Separate Diabetes Business into New Standalone Company

White House, IBM Partner to Fight COVID-19 Using Supercomputers

HHS Sets Pricing Targets for Trump’s EO on Most-Favored-Nation Drug Pricing

23andMe to Mine Genetic Data for Drug Discovery

Regeneron to Acquire Key 23andMe Assets for $256M, Pledges Continuity of Consumer Genome Services

CureIS Healthcare Sues Epic: Alleges Anti-Competitive Practices & Trade Secret Theft

The Evolving Role of Physician Advisors: Bridging the Gap Between Clinicians and Administrators

The Evolving Physician Advisor: From UM to Value-Based Care & AI

UnitedHealth Group Names Stephen Hemsley CEO as Andrew Witty Steps Down

UnitedHealth CEO Andrew Witty Steps Down, Stephen Hemsley Returns as CEO

Omada Health Files for IPO

Omada Health Files for IPO

Blue Cross Blue Shield of Massachusetts Launches "CloseKnit" Virtual-First Primary Care Option

Blue Cross Blue Shield of Massachusetts Launches “CloseKnit” Virtual-First Primary Care Option

Osteoboost Launches First FDA-Cleared Prescription Wearable Nationwide to Combat Low Bone Density

Osteoboost Launches First FDA-Cleared Prescription Wearable Nationwide to Combat Low Bone Density

2019 MedTech Breakthrough Award Category Winners Announced

MedTech Breakthrough Announces 2025 MedTech Breakthrough Award Winners

Secondary Sidebar

Footer

Company

  • About Us
  • Advertise with Us
  • Reprints and Permissions
  • Submit An Op-Ed
  • Contact
  • Subscribe

Editorial Coverage

  • Opinion
  • Health IT
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Population Health Management
    • Revenue Cycle Management
  • Digital Health
    • Artificial Intelligence
    • Blockchain Tech
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • Value-Based Care
    • Accountable Care
    • Medicare Advantage

Connect

Subscribe to HIT Consultant Media

Latest insightful articles delivered straight to your inbox weekly

Copyright © 2025. HIT Consultant Media. All Rights Reserved. Privacy Policy |